Nathan offers over eighteen years of experience in intellectual property law, specializing in the development, licensing and management of patent portfolios, in addition to providing invalidity, infringement, and clearance opinions relating to intellectual property rights.
Nathan has extensive experience in preparing patent applications for a broad range of advanced technologies, including biotechnology, diagnostics, high-throughput pharmaceutical screening, medicinal chemistry, nanotechnology, and specialty chemicals. The specific fields of expertise in which he has prepared and prosecuted patent applications include agricultural biotechnology, antibodies, cardiovascular disease, combinatorial chemistry, gene therapy, genetically engineered plants, heterocyclic chemicals, nutraceuticals, mass spectrometry, oncology, polysaccharides, recombinant biologicals, and ribozymes. He has prosecuted patents for small and large biotechnology companies, chemical and pharmaceutical companies, and research universities. Furthermore, he also has several years of litigation experience working as an associate in a series of veterinary patent litigations.
Nathan regularly lectures on intellectual property and technology, predominantly focusing on issues concerning start-ups and federally-funded inventions. His professional designations include memberships in the American Association for the Advancement of Science, American Association of Clinical Chemistry, Association of University Technology Managers, Licensing Executives Society, and the North Carolina Council for Entrepreneurial Development (CED).
Nathan’s prior roles include serving as vice president for Intellectual Property and Licensing at diaDexus, Inc. (South San Francisco); an attorney position in the firm of Pennie & Edmonds LLP (New York); and a scientific advisor/patent agent in the firm of Cooper & Dunham LLP (New York).
In particular, Nathan’s former role as sole in-house counsel for a biotechnology start-up, including responsibility for in-licensing and out-licensing, corporate compliance, patent strategy and patent portfolio management, led to a patent portfolio that formed the basis for a multi-million dollar spin-out.
- B.A., Chemistry, Hamilton College, NY, 1983
- Ph.D., Organic Chemistry, Columbia University, NY, 1991
NIH/NSF Pre-doctoral Fellow; President, Chemistry Graduate Student Association; Research Advisor, Professor Ronald Breslow
- J.D., Fordham University School of Law, NY, 1996
- New York
- New Jersey
- North Carolina
- U.S. Patent and Trademark Office
- Member, American Association for the Advancement of Science
- Member, Association of University Technology Managers
- Member, Licensing Executives Society
- Member, North Carolina Council for Entrepreneurial Development
- Member, American Association of Clinical Chemistry
- Boehringer Ingelheim Vetmedica, Inc. v. Schering-Plough Corp., (D.N.J. 2000): Represented plaintiff in patent infringement litigation.
- “Prosecuting Biotechnology Patent Applications,” In Pfeffer ed. 10th Annual Patent Prosecution Workshop: Advanced Claim Drafting & Amendment Writing, Practicing Law Institute (PLI), New York, 2000, pg. 497-552;
- “Prosecuting Biotechnology Patent Applications,” in Pfeffer ed. 9th Annual Patent Prosecution Workshop: Advanced Claim Drafting & Amendment Writing, PLI, New York, 1999, pg. 473-534.